Dialog Box

Clinical Trials Now Recruiting

If you would like to learn more about any of the studies currently being conducted at the Skin & Cancer Foundation Inc, please contact the nominated study coordinator.

If you have any general questions regarding the clinical trials conducted at the Foundation, please feel free to contact the Clinical Trials Department at trials@skincancer.asn.au or by 'phone on (03) 9623 9439.

52 WEEK PLAQUE PSORIASIS RESEARCH STUDY 

(60 weeks in total including screening and follow up)

Men and women aged 18 years or older, with stable plaque psoriasis for 6 months or more, may qualify to receive investigational medication (active drug), placebo and/or active comparator.

To be eligible, participants must have plaque psoriasis that covers 10% or more of their body surface area (or an area equal to 10 hand-sized patches). Moderate to severe disease must be present at the time of study entry. Qualified participants will have regular visits with  an experienced research team. There is no cost to participate, and participants will be reimbursed for study-related expenses. Individuals  will be asked to visit the study centre about 18 times over a period of up to 60 weeks. 

For more information, please contact:

Principal Investigator:
A/Prof Peter Foley

Sub Investigator:
Dr Natalie Wong
t: 03 9623 9400
e: nwong@skincancer.asn.au

Trials Manager:
Sarah Chivers
t: 9623 9465
e: schivers@skincancer.asn.au

ADULT ECZEMA RESEARCH STUDY

Adults aged 18 to 75 years old with chronic eczema (atopic dermatitis), may qualify to receive investigational oral medication (active drug) or placebo, during the initial treatment period. During the extension period, individuals who previously received placebo will receive active drug.

To be eligible, participants must have atopic dermatitis involving 10% of their body surface area (or an area equal to 10 palm-sized patches). Moderate to severe disease severity must be present at the time of study entry, along with an onset of symptoms at least 3 years ago. Qualified participants will have regular visits with an experienced research team. There is no cost to participate, and participants will be reimbursed for study-related expenses.

Individuals will be asked to visit the study centre about 21 times over a period of about 34 months. For more information, please contact:

Principal Investigator:
A/Prof Peter Foley

Sub Investigator:
Dr Natalie Wong
t: 9623 9400
e: nwong@skincancer.asn.au

Study Coordinator:
Charlotte Harrison-Mullan
t: 9623 9470
e: charrison@skincancer.asn.au

CHRONIC ECZEMA RESEARCH STUDY (74 Weeks)

Adults aged 18 to 75 with a clinical diagnosis of chronic atopic dermatitis (eczema) for at least 2 years, may qualify to receive investigational medication (either active study drug or placebo).

To be eligible, participants must have atopic dermatitis involving 10% or more of their body surface area (or an area equal to 10 palm-sized patches). Moderate to severe disease severity must be present at the time of study entry. Qualified participants will have regular visits with an experienced research team. There is no cost to participate, and participants will be reimbursed for reasonable travel expenses.

Individuals will be asked to visit the study centre about 30 times over a period of about 74 weeks.

For more information, please contact:

Principal Investigator:
A/Prof Peter Foley

Sub Investigator:
Dr Natalie Wong
t: 03 9623 9400
e: nwong@skincancer.asn.au

Study Coordinator:
Jennifer Kaiser
t: 9623 9420
e: jkaiser@skincancer.asn.au

ECZEMA TRIAL TESTING ORAL MEDICATION

Adults aged 18 years or older with eczema (atopic dermatitis) for at least 1 year, may qualify to receive investigational oral medication (active study drug), an active comparator via injection or placebo.

To be eligible, participants must have eczema involving 10% or more of their body surface area (or an area equal to 10 palm-sized patches). Moderate to severe disease severity must be present at the time of study entry. Qualified participants will have regular visits with an experienced research team. There is no cost to participate, and participants will be reimbursed for study-related expenses.

Individuals will be asked to visit the study centre about 10 times over a period of about 28 weeks. For more information, please contact:

Principal Investigator:
A/Prof Peter Foley

Sub Investigator:
Dr Natalie Wong
t: 9623 9400
e: nwong@skincancer.asn.au

Clinical Trial Manager:
Sarah Chivers
t: 9623 9465
e: schivers@skincancer.asn.au

TOPICAL ECZEMA RESEARCH STUDY (14 Weeks)

Men and women aged 18 years or older with a history of eczema (atopic dermatitis) for at least 1 year, may qualify to receive investigational topical medication (active drug) or placebo.   

To be eligible, participants must have atopic dermatitis involving 5-50% of their body surface area (or an area equal to 5-50 palm-sized patches).  Mild to severe disease severity must be present at the time of study entry. Qualified participants will have regular visits with an experienced research team. There is no cost to participate, and participants will be reimbursed for study-related expenses.

Individuals will be asked to visit the study centre about 8 times over a period of about 14 weeks.

For more information, please contact:

Principal Investigator:
A/Prof Peter Foley

Sub Investigator:
Dr Natalie Wong
t: 9623 9400
e: nwong@skincancer.asn.au

Study Coordinator:
Tracy Mallett
t: 9623 9406
e: tmallett@skincancer.asn.au

2 YEAR ECZEMA (ATOPIC DERMATITIS) RESEARCH STUDY 

Men and women aged 18 years or older, diagnosed with atopic dermatitis (eczema) for at least 12 months, may qualify to receive investigational oral medication. During Treatment Period 1, all participants will receive active drug. During Treatment Period 2, participants may receive active drug or placebo.

To be eligible, participants must have eczema that covers 10% or more of their body surface area (or an area equal to 10 palm-sized patches). Moderate to severe disease must be present at the time of study entry. Qualified participants will have regular visits with an experienced research team. There is no cost to participate, and participants will be reimbursed for study-related expenses.

Individuals will be asked to visit the study centre about 18 times over a period of about 2 years.

For more information, please contact:

Principal Investigator:
A/Prof Peter Foley

Sub Investigator:
Dr Natalie Wong
t: 9623 9400
e: nwong@skincancer.asn.au

Study Coordinator:
Charlotte Harrison-Mullan
t: 9623 9470
e: charrison@skincancer.asn.au

ALOPECIA AREATA TRIAL TESTING ORAL MEDICATION

Adults aged 18 years or older with a diagnosis of alopecia areata (hair loss), may qualify to receive investigational oral medication (active study drug) or placebo.   

To be eligible, participants must have 50% or more hair loss of the scalp, without evidence of terminal hair regrowth within 6 months.  Current episode of hair loss must have occurred within 10 years. Qualified participants will have regular visits with an experienced research team. There is no cost to participate, and participants will be reimbursed for study-related expenses.

Individuals will be asked to visit the study centre about 14 times over a period of about 57 weeks.

For more information, please contact:

Principal Investigator:
A/Prof Peter Foley

Sub Investigator:
Dr Natalie Wong
t: 9623 9400
e: nwong@skincancer.asn.au

Study Coordinator:
Sara Collis
t: 9623 9420
e: scollis@skincancer.asn.au

How do I become involved in a clinical trial at the Foundation?

Anyone can participate in a clinical trial. A referral from a doctor is not necessary.

Contact the Clinical Trials Department directly to inquire about current research projects to determine your suitability
Phone: (03) 9623 9439
Email: trials@skincancer.asn.au

Donate